# Efficacy and Safety of Chinese Herb Medicine-Moxibustion Therapy on Chemotherapy-Induced Leukopenia

> **NCT06262542** · NA · UNKNOWN · sponsor: **Taichung Armed Forces General Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Cancer, Chemotherapy-induced Leukopenia, Chinese Herb Medicine-moxibustion

## Interventions

- **OTHER:** moxibustion and Chinese herbal medicine group

## Key facts

- **NCT ID:** NCT06262542
- **Lead sponsor:** Taichung Armed Forces General Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-03-13
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06262542

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06262542, "Efficacy and Safety of Chinese Herb Medicine-Moxibustion Therapy on Chemotherapy-Induced Leukopenia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06262542. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*